| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.876 | 0.003 | 0.876 | Epidermal growth factor receptor kinase inhibitor | 0.473 0.005 CID_154700142 | ||
| 0.85 | 0.002 | 0.85 | ErbB-1 antagonist | 0.652 0.004 CID_154700142 | ||
| 0.798 | 0.003 | 0.798 | Epidermal growth factor antagonist | 0.362 0.005 CID_154700142 | ||
| 0.759 | 0.005 | 0.759 | Growth factor antagonist | 0.253 0.034 CID_154700142 | ||
| 0.664 | 0.011 | 0.664 | Aldehyde oxidase inhibitor | |||
| 0.642 | 0.004 | 0.642 | ErbB-2 antagonist | 0.261 0.006 CID_154700142 | ||
| 0.601 | 0.016 | 0.601 | Angiogenesis inhibitor | 0.537 0.024 CID_154700142 | ||
| 0.554 | 0.006 | 0.554 | Vascular endothelial growth factor antagonist | 0.112 0.074 CID_154700142 | ||
| 0.532 | 0.007 | 0.532 | Vascular endothelial growth factor 2 antagonist | 0.087 0.082 CID_154700142 | ||
| 0.516 | 0.005 | 0.516 | RET inhibitor | 0.116 0.082 CID_154700142 | ||
| 0.507 | 0.004 | 0.507 | MAP kinase kinase 2 inhibitor | |||
| 0.466 | 0.005 | 0.466 | Ephrin antagonist | 0.256 0.014 CID_154700142 | ||
| 0.464 | 0.007 | 0.649 | DNA methylase inhibitor | 0.649 0.003 CID_154700142 | CID_154700142 | |
| 0.449 | 0.019 | 0.449 | DNA damaging | 0.449 0.019 CID_154700142 | ||
| 0.434 | 0.008 | 0.434 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.211 0.064 CID_154700142 | ||
| 0.421 | 0.005 | 0.421 | Platelet activating factor beta antagonist | 0.101 0.062 CID_154700142 | ||
| 0.426 | 0.016 | 0.426 | Platelet aggregation inhibitor | 0.292 0.038 CID_154700142 | ||
| 0.41 | 0.005 | 0.41 | Protein kinase (CK2) alpha inhibitor | |||
| 0.416 | 0.011 | 0.416 | Src kinase inhibitor | 0.132 0.097 CID_154700142 | ||
| 0.406 | 0.004 | 0.406 | MAP kinase kinase inhibitor | |||
| 0.399 | 0.01 | 0.399 | Vascular endothelial growth factor 3 antagonist | |||
| 0.387 | 0.003 | 0.387 | EphB4 antagonist | 0.087 0.021 CID_154700142 | ||
| 0.386 | 0.009 | 0.386 | c-Src kinase inhibitor | 0.101 0.089 CID_154700142 | ||
| 0.368 | 0.004 | 0.368 | ErbB-4 antagonist | 0.155 0.02 CID_154700142 | ||
| 0.355 | 0.007 | 0.355 | Platelet activating factor antagonist | 0.115 0.066 CID_154700142 | ||
| 0.368 | 0.032 | 0.368 | Tyrosine kinase inhibitor | |||
| 0.334 | 0.004 | 0.334 | ErbB-3 antagonist | 0.216 0.008 CID_154700142 | ||
| 0.34 | 0.013 | 0.34 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.328 | 0.005 | 0.328 | Raf kinase C inhibitor | |||
| 0.339 | 0.016 | 0.511 | DNA methyltransferase I inhibitor | 0.511 0.004 CID_154700142 | CID_154700142 | |
| 0.419 | 0.105 | 0.535 | Apoptosis agonist | 0.535 0.064 CID_154700142 | CID_154700142 | |
| 0.312 | 0.005 | 0.312 | Protein kinase (CK2) inhibitor | |||
| 0.329 | 0.025 | 0.329 | CDC-like kinase 4 inhibitor | |||
| 0.303 | 0.004 | 0.303 | EphA2 antagonist | 0.264 0.005 CID_154700142 | ||
| 0.308 | 0.01 | 0.308 | Vascular endothelial growth factor 1 antagonist | 0.095 0.069 CID_154700142 | ||
| 0.31 | 0.014 | 0.31 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.14 0.083 CID_154700142 | ||
| 0.32 | 0.034 | 0.32 | Clk dual-specificity kinase inhibitor | |||
| 0.297 | 0.04 | 0.297 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.308 | 0.062 | 0.308 | Hypoxia-inducible factor 1 alpha inhibitor | 0.283 0.074 CID_154700142 | ||
| 0.356 | 0.11 | 0.469 | 5 Hydroxytryptamine release inhibitor | 0.469 0.043 CID_154700142 | CID_154700142 | |
| 0.247 | 0.002 | 0.247 | Fructose-1,6-bisphosphatase inhibitor | 0.043 0.034 CID_154700142 | ||
| 0.247 | 0.007 | 0.247 | MAP kinase kinase 5 inhibitor | 0.189 0.048 CID_154700142 | ||
| 0.293 | 0.055 | 0.293 | Dyrk kinase inhibitor | |||
| 0.259 | 0.023 | 0.259 | Lck kinase inhibitor | |||
| 0.232 | 0.011 | 0.232 | Breast cancer-resistant protein inhibitor | 0.095 0.06 CID_154700142 | ||
| 0.256 | 0.035 | 0.256 | LIM domain kinase 1 inhibitor | |||
| 0.219 | 0.004 | 0.219 | MAP kinase kinase 1 inhibitor | |||
| 0.222 | 0.013 | 0.55 | Cyclooxygenase 3 inhibitor | 0.55 0.003 CID_154700142 | CID_154700142 | |
| 0.264 | 0.062 | 0.264 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.254 | 0.058 | 0.254 | Antimitotic | 0.141 0.13 CID_154700142 | ||
| 0.212 | 0.016 | 0.212 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.241 | 0.049 | 0.241 | CDC-like kinase 2 inhibitor | |||
| 0.202 | 0.016 | 0.202 | Platelet activating factor alpha antagonist | |||
| 0.187 | 0.006 | 0.187 | Fibroblast growth factor 2 antagonist | |||
| 0.283 | 0.105 | 0.634 | Transcription factor NF kappa B inhibitor | 0.634 0.027 CID_154700142 | CID_154700142 | |
| 0.234 | 0.059 | 0.234 | Death-associated protein kinase 3 inhibitor | |||
| 0.184 | 0.011 | 0.184 | Platelet growth factor antagonist | 0.09 0.048 CID_154700142 | ||
| 0.199 | 0.037 | 0.199 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.177 | 0.015 | 0.177 | Raf kinase inhibitor | |||
| 0.167 | 0.012 | 0.167 | Raf kinase B inhibitor | |||
| 0.167 | 0.019 | 0.167 | Multidrug resistance-associated protein 1 inhibitor | 0.164 0.02 CID_154700142 | ||
| 0.183 | 0.036 | 0.183 | Aurora-B kinase inhibitor | |||
| 0.204 | 0.059 | 0.204 | Growth factor agonist | 0.151 0.139 CID_154700142 | ||
| 0.219 | 0.075 | 0.219 | EphB2 antagonist | |||
| 0.217 | 0.077 | 0.217 | RNA-directed DNA polymerase inhibitor | 0.168 0.157 CID_154700142 | ||
| 0.175 | 0.036 | 0.175 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.174 | 0.036 | 0.174 | Abl kinase inhibitor | |||
| 0.136 | 0.005 | 0.136 | Heat shock protein 90 beta antagonist | |||
| 0.161 | 0.03 | 0.161 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.178 | 0.049 | 0.178 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.175 | 0.049 | 0.175 | Activin receptor-like kinase 2 inhibitor | |||
| 0.157 | 0.043 | 0.157 | Aurora-C kinase inhibitor | |||
| 0.192 | 0.079 | 0.192 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.126 | 0.024 | 0.126 | Bcr-Abl kinase inhibitor | |||
| 0.163 | 0.06 | 0.163 | CDC-like kinase 1 inhibitor | |||
| 0.158 | 0.057 | 0.158 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.296 | 0.198 | 0.296 | Caspase 9 stimulant | 0.257 0.245 CID_154700142 | ||
| 0.139 | 0.042 | 0.139 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.16 | 0.064 | 0.16 | Heat shock protein 90 antagonist | |||
| 0.121 | 0.025 | 0.121 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.097 | 0.003 | 0.097 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.128 | 0.034 | 0.128 | CDC-like kinase 3 inhibitor | |||
| 0.183 | 0.09 | 0.183 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.123 | 0.032 | 0.123 | Insulin growth factor antagonist | |||
| 0.148 | 0.059 | 0.148 | Tubulin antagonist | |||
| 0.12 | 0.031 | 0.12 | TIE antagonist | |||
| 0.119 | 0.03 | 0.119 | TIE-2 antagonist | |||
| 0.284 | 0.198 | 0.284 | MAP kinase 1 inhibitor | |||
| 0.126 | 0.04 | 0.126 | Fibroblast growth factor 1 antagonist | |||
| 0.148 | 0.064 | 0.148 | MAP3K9 inhibitor | |||
| 0.108 | 0.026 | 0.108 | Purinergic P2X2 antagonist | |||
| 0.129 | 0.05 | 0.129 | Aurora-A kinase inhibitor | |||
| 0.172 | 0.093 | 0.172 | Amyloid beta aggregation inhibitor | |||
| 0.102 | 0.029 | 0.102 | Keratolytic | |||
| 0.19 | 0.117 | 0.19 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.108 | 0.036 | 0.108 | Insulin like growth factor 1 antagonist | |||
| 0.126 | 0.054 | 0.126 | Interleukin 8 antagonist | |||
| 0.071 | 0.009 | 0.071 | Phosphoglycerate kinase inhibitor | |||
| 0.1 | 0.044 | 0.1 | Phosphodiesterase I inhibitor | |||
| 0.094 | 0.038 | 0.094 | Vanilloid antagonist | |||
| 0.078 | 0.024 | 0.078 | Phosphodiesterase 1B inhibitor | |||
| 0.085 | 0.034 | 0.085 | Vanilloid 1 antagonist | |||
| 0.151 | 0.1 | 0.151 | TRKC antagonist | |||
| 0.128 | 0.078 | 0.146 | CC chemokine 6 receptor antagonist | 0.146 0.027 CID_154700142 | CID_154700142 | |
| 0.083 | 0.039 | 0.083 | MAP kinase kinase 7 inhibitor | |||
| 0.079 | 0.036 | 0.079 | ZAP-70 protein tyrosine kinase inhibitor | |||
| 0.086 | 0.047 | 0.086 | Transforming growth factor beta 3 antagonist | |||
| 0.078 | 0.04 | 0.078 | Glutamate (mGluR group I) antagonist | |||
| 0.045 | 0.007 | 0.045 | Estrogen-related receptor beta antagonist | |||
| 0.115 | 0.079 | 0.115 | TRKB antagonist | |||
| 0.076 | 0.044 | 0.076 | Syk tyrosine kinase inhibitor | |||
| 0.133 | 0.1 | 0.133 | GABA C receptor rho-2 antagonist | |||
| 0.095 | 0.064 | 0.175 | Xanthine oxidase inhibitor | 0.175 0.026 CID_154700142 | CID_154700142 | |
| 0.086 | 0.055 | 0.086 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.079 | 0.049 | 0.079 | MAP kinase 7 inhibitor | |||
| 0.091 | 0.06 | 0.091 | Polo-like kinase-1 inhibitor | |||
| 0.095 | 0.069 | 0.095 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.077 | 0.055 | 0.077 | Macrophage migration inhibitory factor inhibitor | |||
| 0.049 | 0.03 | 0.049 | Glutamate (mGluR5) antagonist | |||
| 0.129 | 0.112 | 0.129 | Heat shock protein 90 alpha antagonist | |||
| 0.042 | 0.026 | 0.042 | Thymidine kinase inhibitor | |||
| 0.051 | 0.035 | 0.051 | Antiviral (Hepatitis D) | |||
| 0.026 | 0.012 | 0.026 | Adenosine kinase inhibitor | |||
| 0.103 | 0.088 | 0.103 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.071 | 0.06 | 0.071 | Glutamate (mGluR) antagonist | |||
| 0.046 | 0.035 | 0.046 | Proto-oncogene tyrosine-protein kinase Met inhibitor | |||
| 0.055 | 0.045 | 0.055 | CDK9/cyclin T1 inhibitor | |||
| 0.034 | 0.024 | 0.034 | Purinergic P2X3 antagonist | |||
| 0.027 | 0.021 | 0.027 | DNA polymerase III inhibitor | |||
| 0.124 | 0.119 | 0.124 | Polo-like kinase-3 inhibitor | |||
| 0.075 | 0.07 | 0.075 | AXL receptor tyrosine kinase inhibitor | |||
| 0.07 | 0.066 | 0.07 | Fibroblast growth factor 3 antagonist | |||
| 0.066 | 0.063 | 0.066 | Protein kinase B gamma inhibitor | |||
| 0.083 | 0.08 | 0.083 | Check point kinase 2 inhibitor | |||
| 0.025 | 0.023 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.021 | 0.02 | 0.023 | Adenosine A1 receptor agonist | 0.023 0.018 CID_154700142 | CID_154700142 | |
| 0.141 | 0.158 | 0.354 | Free radical scavenger | 0.354 0.038 CID_154700142 | CID_154700142 | |
| 0.088 | 0.105 | 0.19 | Alkylator | 0.19 0.029 CID_154700142 | CID_154700142 | |
| 0.074 | 0.095 | 0.087 | T cell inhibitor | 0.087 0.043 CID_154700142 | CID_154700142 | |
| 0.099 | 0.124 | 0.194 | Protein kinase stimulant | 0.194 0.044 CID_154700142 | CID_154700142 | |
| 0.125 | 0.156 | 0.224 | ATPase inhibitor | 0.224 0.022 CID_154700142 | CID_154700142 | |
| 0.077 | 0.109 | 0.11 | Interleukin 12 antagonist | 0.11 0.04 CID_154700142 | CID_154700142 | |
| 0.071 | 0.108 | 0.098 | Thioredoxin inhibitor | 0.098 0.051 CID_154700142 | CID_154700142 | |
| 0.074 | 0.124 | 0.094 | DNA polymerase I inhibitor | 0.094 0.092 CID_154700142 | CID_154700142 | |
| 0.038 | 0.097 | 0.047 | Factor III inhibitor | 0.047 0.042 CID_154700142 | CID_154700142 | |
| 0.103 | 0.17 | 0.254 | Nitric oxide antagonist | 0.254 0.05 CID_154700142 | CID_154700142 | |
| 0.018 | 0.094 | 0.029 | Toll-Like receptor 4 agonist | 0.029 0.013 CID_154700142 | CID_154700142 | |
| 0.06 | 0.149 | 0.115 | Transcription factor NF kappa B stimulant | 0.115 0.028 CID_154700142 | CID_154700142 | |
| 0.12 | 0.21 | 0.366 | Antioxidant | 0.366 0.042 CID_154700142 | CID_154700142 | |
| 0.04 | 0.135 | 0.086 | Topoisomerase II alpha inhibitor | 0.086 0.049 CID_154700142 | CID_154700142 | |
| 0.146 | 0.247 | 0.311 | Vasodilator, coronary | 0.311 0.079 CID_154700142 | CID_154700142 | |
| 0.054 | 0.159 | 0.1 | ATPase (Vacuolar H+) inhibitor | 0.1 0.04 CID_154700142 | CID_154700142 | |
| 0.03 | 0.135 | 0.062 | Glucose-6-phosphate translocase inhibitor | 0.062 0.022 CID_154700142 | CID_154700142 | |
| 0.154 | 0.263 | 0.19 | Caspase 3 stimulant | 0.19 0.185 CID_154700142 | CID_154700142 | |
| 0.055 | 0.166 | 0.093 | NADH dehydrogenase inhibitor | 0.093 0.052 CID_154700142 | CID_154700142 | |
| 0.157 | 0.27 | 0.328 | Histamine release inhibitor | 0.328 0.11 CID_154700142 | CID_154700142 | |
| 0.115 | 0.233 | 0.247 | Cyclic AMP phosphodiesterase inhibitor | 0.247 0.065 CID_154700142 | CID_154700142 | |
| 0.205 | 0.327 | 0.607 | Antiinflammatory | 0.607 0.052 CID_154700142 | CID_154700142 | |
| 0.141 | 0.269 | 0.389 | Immunosuppressant | 0.389 0.068 CID_154700142 | CID_154700142 | |
| 0.149 | 0.278 | 0.275 | Toll-Like receptor agonist | 0.275 0.128 CID_154700142 | CID_154700142 | |
| 0.144 | 0.287 | 0.256 | Toll-Like receptor 7 agonist | 0.256 0.143 CID_154700142 | CID_154700142 | |
| 0.056 | 0.219 | 0.125 | Toll-Like receptor 4 antagonist | 0.125 0.039 CID_154700142 | CID_154700142 | |
| 0.024 | 0.217 | 0.055 | Factor IXa inhibitor | 0.055 0.031 CID_154700142 | CID_154700142 | |
| 0.031 | 0.225 | 0.108 | Topoisomerase I inhibitor | 0.108 0.063 CID_154700142 | CID_154700142 | |
| 0.109 | 0.304 | 0.253 | DNA synthesis inhibitor | 0.253 0.064 CID_154700142 | CID_154700142 | |
| 0.047 | 0.245 | 0.14 | Lipid peroxidase inhibitor | 0.14 0.076 CID_154700142 | CID_154700142 | |
| 0.053 | 0.269 | 0.434 | Angiogenesis stimulant | 0.434 0.017 CID_154700142 | CID_154700142 | |
| 0.006 | 0.224 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.018 CID_154700142 | CID_154700142 | |
| 0.007 | 0.231 | 0.027 | Sodium/glucose cotransporter inhibitor | 0.027 0.015 CID_154700142 | CID_154700142 | |
| 0.089 | 0.318 | 0.417 | Hypoglycemic | 0.417 0.025 CID_154700142 | CID_154700142 | |
| 0.008 | 0.237 | 0.023 | Protein 30S ribosomal subunit inhibitor | 0.023 0.018 CID_154700142 | CID_154700142 | |
| 0.067 | 0.332 | 0.2 | Non-steroidal antiinflammatory agent | 0.2 0.071 CID_154700142 | CID_154700142 | |
| 0.111 | 0.385 | 0.299 | Apoptosis antagonist | 0.299 0.086 CID_154700142 | CID_154700142 | |
| 0.063 | 0.337 | 0.153 | Insulin secretagoues | 0.153 0.071 CID_154700142 | CID_154700142 | |
| 0.028 | 0.312 | 0.096 | Topoisomerase II inhibitor | 0.096 0.09 CID_154700142 | CID_154700142 | |
| 0.059 | 0.36 | 0.271 | Hepatoprotectant | 0.271 0.038 CID_154700142 | CID_154700142 | |
| 0.021 | 0.323 | 0.105 | Expectorant | 0.105 0.063 CID_154700142 | CID_154700142 | |
| 0.058 | 0.375 | 0.338 | Tumour necrosis factor alpha release inhibitor | 0.338 0.041 CID_154700142 | CID_154700142 | |
| 0.063 | 0.384 | 0.125 | Interferon gamma antagonist | 0.125 0.121 CID_154700142 | CID_154700142 | |
| 0.053 | 0.393 | 0.18 | Vasodilator | 0.18 0.122 CID_154700142 | CID_154700142 | |
| 0.073 | 0.426 | 0.43 | Antithrombotic | 0.43 0.042 CID_154700142 | CID_154700142 | |
| 0.009 | 0.375 | 0.204 | Selectin antagonist | 0.204 0.011 CID_154700142 | CID_154700142 | |
| 0.036 | 0.407 | 0.129 | Cell adhesion inhibitor | 0.129 0.059 CID_154700142 | CID_154700142 | |
| 0.038 | 0.408 | 0.274 | Immunostimulant | 0.274 0.087 CID_154700142 | CID_154700142 | |
| 0.006 | 0.378 | 0.075 | Antineoplastic antibiotic | 0.075 0.061 CID_154700142 | CID_154700142 | |
| 0.022 | 0.475 | 0.18 | Thrombolytic | 0.18 0.062 CID_154700142 | CID_154700142 | |
| 0.085 | 0.555 | 0.29 | Peptidyltransferase inhibitor | 0.29 0.028 CID_154700142 | CID_154700142 | |
| 0.058 | 0.537 | 0.244 | Immunomodulator | 0.244 0.12 CID_154700142 | CID_154700142 | |
| 0.066 | 0.58 | 0.516 | Cyclophilin D inhibitor | 0.516 0.046 CID_154700142 | CID_154700142 | |
| 0.009 | 0.557 | 0.06 | Protein 50S ribosomal subunit inhibitor | 0.06 0.031 CID_154700142 | CID_154700142 | |
| 0.017 | 0.573 | 0.121 | Anticoagulant | 0.121 0.11 CID_154700142 | CID_154700142 | |
| 0.011 | 0.569 | 0.05 | Antibiotic Aminoglycoside-like | 0.05 0.014 CID_154700142 | CID_154700142 | |
| 0.024 | 0.597 | 0.121 | Hemostatic | 0.121 0.113 CID_154700142 | CID_154700142 | |
| 0.018 | 0.748 | 0.143 | Platelet adhesion inhibitor | 0.143 0.114 CID_154700142 | CID_154700142 | |
| 0.008 | 0.825 | 0.303 | Antibacterial | 0.303 0.133 CID_154700142 | CID_154700142 | |
| 0.043 | 0.875 | 0.254 | Interleukin 2 agonist | 0.254 0.114 CID_154700142 | CID_154700142 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |